Condition
Ig-E Mediated Food Allergy
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Recruiting2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07220811Phase 2RecruitingPrimary
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
NCT07408869Phase 1Not Yet Recruiting
A Phase 1 Study of Cizutamig in IgE Mediated Diseases
NCT02106169Not ApplicableCompletedPrimary
Impact of the Therapeutic Education on the Quality of Life of the Child Suffering of Food Allergy IgE-mediated
NCT07341776Phase 4Recruiting
Steroid Use in Treatment of Allergic Reactions to Food
NCT04643704Completed
Quality of Life and Eating Disorders in Children With FPIES, Food Allergy or Celiac Disease
Showing all 5 trials